Back
Aligos Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
60
ALGS
Aligos Therapeutics
Last Price:
$8.65
Seasonality Move:
-13.29%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight buying pressure.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.48 | Buy |
| 20-day SMA: | 7.63 | Buy |
| 50-day SMA: | 6.4 | Buy |
| 200-day SMA: | 15.22 | Sell |
| 8-day EMA: | 7.66 | Buy |
| 20-day EMA: | 7.38 | Buy |
| 50-day EMA: | 7.5 | Buy |
| 200-day EMA: | 13.03 | Sell |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 59.47 | Buy |
| Chaikin Money Flow: | 56951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.59 - 8.07) | Buy |
| Bollinger Bands (100): | (4.08 - 13.62) | Sell |
Aligos Therapeutics Technical Analysis
| Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 8.24 while ALGS 8-day simple moving average is 7.48, which is a Buy signal.
-
The stock price of ALGS is 8.24 while Aligos Therapeutics 20-day SMA is 7.63, which makes it a Buy.
-
Aligos Therapeutics 50-day simple moving average is 6.40 while ALGS share price is 8.24, making it a Buy technically.
-
ALGS stock price is 8.24 and Aligos Therapeutics 200-day simple moving average is 15.22, creating a Sell signal.
ALGS Technical Analysis vs Fundamental Analysis
Buy
60
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a BuyThe current Aligos Therapeutics [ALGS] share price is $8.24. The Score for ALGS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
50.4M
Price in USD:
8.24
Share Volume:
134.9K
Aligos Therapeutics 52-Week Range
52-Week High:
46.80
52-Week Low:
3.76
Buy
60
Aligos Therapeutics (ALGS)
is a Buy
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?The Aligos Therapeutics stock price is 8.24 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is not overvalued.
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 8.24 while ALGS 8-day exponential moving average is 7.66, which is a Buy signal.
-
The stock price of ALGS is 8.24 while Aligos Therapeutics 20-day EMA is 7.38, which makes it a Buy.
-
Aligos Therapeutics 50-day exponential moving average is 7.50 while ALGS share price is 8.24, making it a Buy technically.
-
ALGS stock price is 8.24 and Aligos Therapeutics 200-day simple moving average is 13.03, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Aligos Therapeutics is a Buy
-
Aligos Therapeutics Relative Strength Index (RSI) is 59.47, which suggest Aligos Therapeutics is overbought
-
The Bollinger Bands (25) for Aligos Therapeutics is (6.59 - 8.07), which suggest Aligos Therapeutics is a Sell
-
The Bollinger Bands (100) for Aligos Therapeutics is (4.08 - 13.62), which suggest Aligos Therapeutics is a Sell
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.